The purpose of this study was to evaluate the feasibility and performance of an augmented reality (AR) visualization prototype for virtual computed tomography (CT)-guided interventional procedures in a multimodality abdominal phantom. With the aid of AR guidance, three radiologists performed 30 attempts at targeting simulated liver lesions of different sizes (range, 5-15 mm) with a biopsy needle. The position of the needle tip relative to the lesion was verified by using ultrasonography and CT. With AR guidance, lesions were successfully targeted with the first needle pass in all cases. On the basis of these results, AR visualization for CT-guided intervention appears feasible and allows intuitive and accurate lesion targeting in a phantom.
C
omputed tomography (CT)-guided interventions have become an integral component of modern patient care (1) . Certain factors, however, make the targeting of lesions more difficult, prolong procedure times, and increase the radiation burden to the patient and operator (1) (2) (3) (4) . Such factors include spatial constraints within the narrow CT gantry opening, locations that are difficult to target, and an increasing number of small lesions. Image-guided navigation for minimally invasive surgery and stereotactic interventions has grown in importance in recent years (5, 6) .
One area of development is the use of augmented reality (AR) visualization to guide medical procedures (7) (8) (9) . The AR system generates a composite view by augmenting the real interventional field viewed by the user with additional information from a virtual scene generated by the computer. In such a setting, AR is used to map cross-sectional medical images into patient space, thereby enabling the physician to perceive images in situ. For example, cross-sectional images that contain a tumor are projected into patient space and appear in the location of the actual tumor. By simultaneously tracking an invasive instrument, such as a biopsy needle, the AR system can project the instrument into the same space so that the operator can perform needle placement with AR guidance.
Since its initial description, AR for medical applications has been refined continuously (9) (10) (11) . The basic underlying principles and technical feasibility of AR navigation have been described in conjunction with neurosurgical settings in the context of an interventional magnetic resonance (MR) imaging suite and with interventional ultrasonography (US) (12) (13) (14) (15) . The purpose of our study was to evaluate the feasibility and performance of an AR visualization prototype for virtual CT-guided interventional procedures in a multimodality abdominal phantom.
Materials and Methods
Authors who were not employees or consultants of Siemens Medical Solutions (Forchheim, Germany) and Siemens Corporate Research (Princeton, NJ) had control of the inclusion of any data and information that might have presented a conflict of interest for those authors who were employees or consultants of Siemens Medical Solutions and Siemens Corporate Research.
System Description
The system used in our study (RAMP; Siemens Corporate Research) is an investigational prototype that is not yet approved by the U.S. Food and Drug Administration. Its centerpiece is a video-see-through head-mounted display (Proview XL 35; Kaiser Electro-Optics, Carlsbad, Calif) that provides the user with augmented vision (Fig 1) . Two miniature color video cameras (a scene camera [GP-KS 1000; Panasonic, Osaka, Japan] and a tracking camera [XC-77RR; Sony, Tokyo, Japan]) serve as the user's artificial eyes and capture live images of the scene. The total weight of the prototype helmet is 3 lbs (1.4 kg) (Fig 1) .
The two live video streams are augmented with computer graphics and are displayed on the two visualization screens of the head-mounted display in real time. Figure 2 shows a system block diagram of the components of the AR guidance setup. With the head-mounted display, the user's motion is unrestricted, allowing for exploration of the augmented scene from a variety of viewpoints. The user's spatial perception is based on stereo depth cues, as well as on the kinetic depth cues that he or she receives with viewpoint variations. The cameras are focused at a distance equal to the operator's arm length and are tilted downward so that the user's head is in a comfortable position. A third head-mounted video camera on the top of the helmet (Fig 1) is used for tracking the user's viewpoint and the invasive instrument.
Tracking
For tracking an invasive instrument in the interventional field, a set of optical markers that reflect infrared light (Scotchlite 8710 Silver Transfer Film; 3M, St Paul, Minn) is attached to a frame, which surrounds the phantom (Fig 3) and is designed to fit into all CT scanner gantries. Another set of optical markers that reflect infrared light is attached to the invasive instrument (ie, the needle) that is used during the pro- cedure (Fig 4) . The markers comprise reflective disk-shaped objects that are arranged in a circular planar fashion. The markers are arranged at several depth levels. The combination of optical marker sets, both on the frame and on the needle, enables tracking of the needle position within the augmented scene, as perceived by the operator. Tracking the needle position in the interventional field is achieved by continuously registering infrared light, which is emitted by a ring of infrared light-emitting diodes that are located around the lens of the tracking camera to illuminate the frame around the phantom with its reflective markers. The tracking camera is sensitive to near-infrared wavelength light only and is not affected by ambient light.
Because the tracking camera is mounted on the helmet, tracking always occurs when the operator's head is aligned with the interventional field. Thus, the line of sight between the tracking camera and the optical markers is not obscured by the operator's body.
Calibration
Baseline system calibration prior to performing a procedure is based on threedimensional (3D) and two-dimensional point correspondence (16) . The 3D coordinates of the markers are measured by using a commercially available stereo system (ARTrack1/DTrack; A.R.T., Herrsching, Germany). The twodimensional positions are based on actual camera images. For calibration of the camera triplet, the position parameters of the two scene cameras are deduced from the position parameters measured with the tracking camera. The registration accuracy of the augmentation that is measured in the object space is 1 mm (16) . The system is operated by a single computer and achieves real-time performance with a latency of 0.1 second, thereby generating stable augmentation. The AR video system uses a full standard video rate of 30 frames per second. Video and graphics are synchronized, which eliminates lag time between visualization of real and virtual objects. Thus, visualization of virtual objects occurs simultaneously with visualization of real objects. The time from system set up and calibration to the initiation of needle tracking is only 5-10 minutes.
Feasibility and Phantom Evaluation
We used a multimodality (CT, US, and MR imaging) interventional 3D abdominal phantom (CIRS, Norfolk, Va) to evaluate the performance of the AR system (Fig 3) . The phantom contains multiple simulated liver lesions that range from 5-15 mm in size (average, 10 mm). The phantom was scanned by using a four-section CT scanner (Sensation 4; Siemens Medical Solutions) with a standard abdominal CT protocol (4 ϫ 1-mm collimation, 120 kV, 150 mAs [effective], and 1.25-mm section thickness). The experimental setup in the scanner gantry is shown in Figure 5 . Sections containing simulated lesions were identified and registered with respect to the phantom. Three-dimensional rendering was performed by the computer for the first 21 of 30 target lesions. To this end, the computergenerated 3D objects were inserted into the real-time video sequence in alignment with the actual target (Fig 6; Movie [radiology.rsnajnls.org/cgi/content/full /2401040018/DC1]).
To assess the accuracy of lesion targeting without prior segmentation and 3D rendering (as a more direct and time-effective approach), targeting was performed without prior graphic 3D enhancement and was solely based on cross-sectional CT images for the remaining nine lesions. Segmented and registered 3D models of the lesions, as well as unsegmented lesions, were then targeted by using the AR device.
Three radiologists with varying levels of experience in CT-guided interventional procedures (1, 6, and 15 years) each performed 10 needle placements (total needle placements, 30) to target the lesions in the phantom. Each of the radiologists tried to target the same lesions in the phantom. The time from needle insertion to successful lesion localization was recorded for each needle placement.
In the augmented scene viewed by the operator, a thin blue-colored cylinder was used to represent the virtual needle (Fig 6; Movie [radiology.rsnajnls .org/cgi/content/full/2401040018/DC1]), and a thin green-colored cylinder (7 cm in length) was used to represent the extrapolated needle trajectory extending from the needle tip (Fig 6; Movie [radiology.rsnajnls.org/cgi/content/full /2401040018/DC1]). The virtual extrapolation of the needle trajectory was used as an aid to align the projected needle path with the center of the lesion. By using the extrapolated trajectory, operators located an appropriate point of entry on the surface of the phantom and a suitable angle of insertion. The tip of the virtual needle was identified as a small sphere at the end of the colored cylinder. The depth and the position of the target lesion were extracted from the CT coordinates, and the time from needle insertion to successful lesion localization was recorded for each needle placement.
Once the lesion was targeted, as indicated by the appearance of the virtual needle tip in the segmented target, the needle was left inside the phantom, and the position of the needle tip was confirmed with US (Elegra; Siemens Medical Solutions) and repeat CT (Fig 7) . The position of the actual needle tip within the phantom was extracted from the CT coordinates and was compared with the location of the virtual needle tip in the AR coordinate system. The distance from the actual or virtual needle tip to the actual or virtual lesion center was calculated in millimeters. On the basis of these values, three types of errors were assessed to gauge the performance of the AR system. Virtual placement error (user error) was expressed as the distance (in millimeters) between the virtual needle tip and the virtual target center. Virtual placement error was calculated as x Ϫ y ϭ z, where x is the virtual needle tip position, y is the virtual target center position, and z is the user accuracy (in millimeters) with AR guidance. This type of error was used to measure the accuracy with which the operator followed AR guidance.
Real placement error was expressed as the distance (in millimeters) between the real target center and the real needle tip, as computed by using verification scans. Real placement error was calculated as a Ϫ b ϭ c, where a is the real target center position, b is the real needle tip position, and c is the real placement error in millimeters. This type of error was used to measure the accuracy of actual needle placement relative to the center of the actual target lesion.
System error was expressed as the distance (in millimeters) between the real needle tip and the virtual needle tip and was calculated as b Ϫ x ϭ d, where d is the accuracy of the AR system in millimeters. This type of error was used to measure the accuracy with which the AR system tracked the needle position.
Data Evaluation
The average target depth and the average time that was needed by the radiologists to target the lesion were calculated. Averages were also calculated by using CT coordinates for virtual placement error, real placement error, and system error.
Results
The average depth of the target lesion relative to the entry point of the biopsy needle was 68 mm (range, 42-88 mm). Use of the navigational device resulted in successful localization of the target lesion in all 30 interventions, as confirmed with US and CT. In each case, the needle tip had contact with at least a portion of the target lesion, with no deviation of the needle tip from the intended target after verification of the needle position with US and CT. Segmented and unsegmented lesions were successfully targeted. Mean targeting time was 8 seconds (range, 5-14 seconds) for successful localization of target lesions. There was no substantial difference in targeting time with respect to the experience of the operator.
In Figure 8 , the three different placement errors are graphically displayed. The distance between the virtual needle tip and the virtual lesion center (virtual placement error) was 2.4 mm on average and ranged from 1.3 to 3.1 mm. The distance between the real needle and the real lesion (real placement error) was also extracted and showed an error of between 2.7 and 4.2 mm, with an average of 3.5 mm. The system error was measured as the distance between the virtual needle and the real needle and ranged from 1.1 to 3.0 mm, with an average of 2.1 mm.
Discussion
Minimally invasive procedures guided by cross-sectional imaging have become firmly established in daily practice (1, 2, 5) and are increasingly offered with either palliative or curative intention to patients who traditionally were not considered candidates for surgery (eg, those scheduled to undergo tumor ablation).
Recent developments in medical image processing and enhanced computer performance have paved the way for the introduction of image-guided navigation into minimally invasive and stereotactic procedures (5-7). The technical basis and feasibility of AR have been described in conjunction with US (15) and MR imaging (12) . The AR system described here merges virtual objects in real time with the real world and firmly anchors them in a video scene. AR visualization provides intuitive access to 3D anatomy and enables the operator to perceive cross-sectional medical images in situ. Guided by an augmented video view that displays the lesion, surrounding anatomy, and invasive instrument, the user can navigate the intervention tool in patient space. The AR system additionally provides an extrapolation of the needle trajectory as a targeting aid.
Image-guided navigation techniques have already been established for a variety of clinical applications (eg, neurosurgery and ear, nose, and throat surgery). However, to date, little use for this technique has been found in crosssectional image-guided intervention, likely because the current CT-guided targeting techniques are satisfactory for the majority of clinical scenarios. Still, there are some aspects that may make AR navigation a helpful addition to the interventional armamentarium in the future. For example, concerns have been raised over increased radiation exposure to both patients and radiologists (3, 4, 17) . The ability to navigate on the basis of previously acquired CT data allows the procedure to be performed without radiation exposure to the interventionalist and those outside the CT scanner gantry, which eliminates the spatial constraint of a narrow gantry opening. Additionally, navigation on the basis of CT data acquired during distinct phases of contrast material enhancement may help avoid vulnerable vascular structures and aid in the targeting of lesions that are only visible during certain perfusion phases. On the basis of our phantom data, we determined that the ability to navigate the interventional tool along a virtual path within a volume of the CT image data greatly facilitates off-plane targeting access. Guiding information is provided as real-time graphic augmentation of a real-time video view with CT data containing the target. In this way, the most suitable access angle can be chosen. At the same time, the actual needle tip is indicated throughout the procedure, thereby enabling the selection of a needle path that avoids vessels or other vulnerable structures. Use of such techniques may be helpful whenever oblique access to the transverse plane is necessary to avoid vital structures. Thus, AR systems may provide better hand-eye coordination by means of 3D perception of navigational information (ie, lesion, needle, and critical structures) in the context of the patient than previous targeting devices that are based on two-dimensional concepts.
Performing minimally invasive procedures that are guided in real time by merged 3D renderings of actual and virtual images is an attractive concept. On the basis of results from our initial phantom experiments, the AR navigation system tested in this study proved intuitive enough to enable accurate lesion targeting, even for less-experienced users. A number of limitations, however, need to be addressed before the results of our initial phantom experiments can be successfully translated to patients.
Obviously, use of AR requires additional room time for system set up and calibration. However, even with this prototype system, these procedures take no longer than 10 minutes. Future iterations in system development and greater user familiarity with the device will result in even shorter setup times. Moreover, because there is a greater chance that the lesion will be targeted accurately with the first needle pass, the overall length of the procedure and the risk of complications from multiple needle passes may be reduced. This first prototype does not account for patient movement, such as respiratory excursion with displacement of the lungs and upper abdominal organs. To allow for successful localization of moving targets, a continuous update of the position of the target lesion relative to the interventional field will be necessary to track the displacement of the anatomy and maintain accurate coregistration of virtual objects and image data. In the case of respiratory motion, strategies such as respiratory gating could compensate for excursions of abdominal organs (eg, CT-guided biopsies are sometimes performed in the liver dome or in other sites where US is less effective). Such procedures are technically more complex and difficult but were not tested with the simple phantom used here. Thus, it is foreseeable that the application of such tools will initially be reserved for cases with complicated but relatively fixed anatomy (eg, for deep retroperitoneal lymphadenopathy and adrenal, renal, or extraperitoneal pelvic lesions) rather than those for which organs could be in motion during needle placement.
While this system proved fairly accurate for targeting lesions in an interventional phantom and had only a few millimeters of error, this error rate may still be problematic when targeting complicated lesions (eg, a deep lymph node adjacent to the abdominal aorta).
In summary, our preliminary phantom experience with the prototype system shows that AR guidance can be successfully used to target small lesions during CT-guided interventions. Although the addition of AR navigation tools to the arsenal of image-guided instruments may broaden the scope of interventional radiology, extensive clinical testing will be needed.
